Page 12 - Biological E News Today

The union health ministry has signed a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees (USD 205.62 million).

Aiming at a stiff vaccination target, the government has booked 30 crore doses of Hyderabad-based Biological-E's Covid vaccine, which is still in clinical trials.

URL copied Centre finalises advance deal with Hyderabad-based firm for 30 crore Covid vaccine doses The Union Ministry of Health has finalised arrangements with Hyderabad based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses. These vaccine doses will be manufactured and stockpiled by M/s Biological-E from August-December 2021.  For this purpose, the Union Ministry of Health would be making an advance payment of Rs. 1500 crore to M/s Biological-E.�...

Centre books 30 cr doses of second made-in-India Covid vaccine from Hyderabad-based Biological-E ANI | Updated: Jun 03, 2021 10:32 IST New Delhi [India], June 3 (ANI): The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. As per a health ministry statement on Thursday, an advance payment of Rs 1,50...

India News: The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a

The vaccine candidate is undergoing phase 3 trials now

The vaccines will be manufactured and stockpiled by Biological-E from August-December 2021

According to sources, the government has signed the deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees (USD 205.62 million).

  >>  Reuters Published: 03 Jun 2021 10:26 AM BdST Updated: 03 Jun 2021 10:26 AM BdST FILE PHOTO: 3D-printed small toy figurines, a syringe and vial labelled "coronavirus disease (COVID-19) vaccine" are seen in front of India flag in this illustration taken May 4, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Indias government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million). "); ...

The Ministry added that it would be making an advance payment of Rs. 1500 crore to the firm.